Federal Multidistrict Litigation Status Multidistrict Litigation 3094, formally titled In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, was established in February 2024 in the Eastern District of Pennsylvania, consolidating cases from across the nation alleging injuries from Ozempic, Wegovy, Rybelsus, Mounjaro, and Trulicity
May 20, 2026: Nitrous Oxide Lawsuits Focus on Influencer Marketing and Missing Health Warnings New nitrous oxide lawsuits are increasingly focusing on the role social media influencers allegedly played in promoting recreational inhalation products without adequate health warnings
Each vial provides a high-potency dose in a convenient liquid form
Photomedicine and Laser Surgery
First, a healthcare professional checks your symptoms and history
It is essential to check your individual policy details or speak with an Aetna representative to understand your coverage options